OptimizeRx Corp - FORM 10-K - EX-23.1 - CONSENT OF MARCUM LLP - March 26, 2020

Attached files

file filename
10-K - ANNUAL REPORT - OptimizeRx Corpf10k2019_optimizerxcorp.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO - OptimizeRx Corpf10k2019ex32-1_optimizerx.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-2_optimizerx.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-1_optimizerx.htm
EX-21.1 - LIST OF SUBSIDIARIES - OptimizeRx Corpf10k2019ex21-1_optimizerx.htm
EX-10.6 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH MIRIAM PARAMORE, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-6_optimizerx.htm
EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH STEPHEN SILVESTRO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-5_optimizerx.htm
EX-10.4 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH WILLIAM FEBBO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-4_optimizerx.htm
EX-10.3 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DOUG BAKER, DATED MARCH 10, 2020 - OptimizeRx Corpf10k2019ex10-3_optimizerx.htm

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in the Registration Statement of OptimizeRx Corporation on Form S-3 (File No. 333-228357) and Form S-8 (File Nos. 333-230212; 333-210653; and 333-189439)  of our report dated March 26, 2020, with respect to our audit of the consolidated financial statements of OptimizeRx Corporation and Subsidiaries as of December 31, 2019 and for the year then ended and our report dated March 26, 2020 with respect to our audit of the effectiveness of internal control over financial reporting of OptimizeRx Corporation as of December 31, 2019, which reports are included in this Annual Report on Form 10-K of OptimizeRx Corporation for the year ended December 31, 2019.

 

Our report on the consolidated financial statements refers to a change in the Company’s method of accounting for leases in 2019 due to the adoption of ASU No. 2016-02, Leases (Topic 842), as amended, effective January 1, 2019, using the modified retrospective approach.

 

Our report on the effectiveness of internal control over financial reporting expressed an adverse opinion because of the existence of material weaknesses.

 

/s/ Marcum llp

 

Marcum llp

New York, NY

March 26, 2020

 

Stock widget

Investing forum

OptimizeRx Corp Reports